The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor agonists.
Disclaimer: This news article has been republished exactly as it appeared on its original source, without any modification. We do not take any responsibility for its content, which remains solely the responsibility of the original publisher.
Author: Meg Hilling
Published on: 2025-11-14 20:16:00
Source: thehill.com
